UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mucins in cancer: function, prognosis and therapy

Nature reviews. Cancer, 2009-12, Vol.9 (12), p.874-885

Kufe, Donald W

2009

Volltextzugriff (PDF)

MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment

Carcinogenesis (New York), 2020-09, Vol.41 (9), p.1173-1183

Kufe, Donald W

2020

Volltextzugriff (PDF)

Functional targeting of the MUC1 oncogene in human cancers

Cancer biology & therapy, 2009-07, Vol.8 (13), p.1197-1203

Kufe, Donald W.

2009

Volltextzugriff (PDF)

Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia

Cancers, 2022-09, Vol.14 (19), p.4805

Kufe, Donald W.

2022

Volltextzugriff (PDF)

MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment

Proceedings of the National Academy of Sciences - PNAS, 2009-04, Vol.106 (14), p.5837-5841

2009

Volltextzugriff (PDF)

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

BMC genomics, 2010-05, Vol.3 (1), p.16-16, Article 16

2010

Volltextzugriff (PDF)

Targeting the human MUC1 oncoprotein: A tale of two proteins

Cancer biology & therapy, 2008-01, Vol.7 (1), p.81-84

Kufe, Donald W.

2008

Volltextzugriff (PDF)

MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells

Cell death discovery, 2024-01, Vol.10 (1), p.9-9, Article 9

2024

Volltextzugriff (PDF)

Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells

Journal of Cancer Metastasis and Treatment, 2022, Vol.8

Kufe, Donald W.

2022

Volltextzugriff (PDF)

MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer

Cancer letters, 2023-04, Vol.559, p.216116-216116, Article 216116

2023

Volltextzugriff (PDF)

Combined effects of angiostatin and ionizing radiation in antitumour therapy

Nature (London), 1998-07, Vol.394 (6690), p.287-291

1998

Volltextzugriff (PDF)

Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily

Journal of clinical oncology, 2002-09, Vol.20 (18), p.3772-3784

2002

Volltextzugriff (PDF)

MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression

Oncogene, 2024-07, Vol.43 (28), p.2199-2214

2024

Volltextzugriff (PDF)

CBP501-calmodulin binding contributes to sensitizing tumor cells to cisplatin and bleomycin

Molecular cancer therapeutics, 2011-10, Vol.10 (10), p.1929-1938

2011

Volltextzugriff (PDF)

CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity

Blood, 2011-10, Vol.118 (14), p.3922-3931

2011

Volltextzugriff (PDF)

A Phase I Trial of TNFerade Biologic in Patients with Soft Tissue Sarcoma in the Extremities

Clinical cancer research, 2004-09, Vol.10 (17), p.5747-5753

2004

Volltextzugriff (PDF)

Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents

Nature (London), 1995-08, Vol.376 (6543), p.785-788

1995

Volltextzugriff (PDF)

CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding

Oncotarget, 2017-09, Vol.8 (43), p.74006-74018

2017

Volltextzugriff (PDF)

Manganese Superoxide Dismutase (SOD2) Inhibits Radiation-Induced Apoptosis by Stabilization of the Mitochondrial Membrane

Radiation research, 2002-05, Vol.157 (5), p.568-577

2002

Volltextzugriff (PDF)

CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice

Oncotarget, 2017-10, Vol.8 (45), p.78277-78288

2017

Volltextzugriff (PDF)

CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathway

Molecular cancer therapeutics, 2014-12, Vol.13 (12), p.3013-3023

2014

Volltextzugriff (PDF)

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches

Oncogene, 2013-02, Vol.32 (9), p.1073-1081

Kufe, D W

2013

Volltextzugriff (PDF)

MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.2833-2837

2009

Volltextzugriff (PDF)

Spatial and temporal control of gene therapy using ionizing radiation

Nature medicine, 1995-08, Vol.1 (8), p.786-791

1995

Volltextzugriff (PDF)

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance

The cancer journal (Sudbury, Mass.), 2002-01, Vol.8 (1), p.47-54

2002

Volltextzugriff (PDF)

1 – 25 von 265

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(243)

Publikationsform

Artikel
(263)
Buchkapitel
(2)

Sprache

Englisch
(265)

Erscheinungsjahr

n.n

Thema

Science & Technology
(205)
Life Sciences & Biomedicine
(197)
Humans
(184)
Biological And Medical Sciences
(127)
Oncology
(111)
Medical Sciences
(99)
Animals
(74)
Pharmacology. Drug Treatments
(60)
Antineoplastic Agents
(59)
Female
(57)
Mice
(55)
Tumor Cells, Cultured
(53)
Tumors
(36)
Male
(35)
Cell Line
(32)
Pharmacology & Pharmacy
(30)
Fundamental And Applied Biological Sciences. Psychology
(29)
Adult
(28)
Middle Aged
(27)
Hematology
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mucins in cancer: function, prognosis and therapy

MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment

Functional targeting of the MUC1 oncogene in human cancers

Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia

MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

Targeting the human MUC1 oncoprotein: A tale of two proteins

MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells

Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells

MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer

Combined effects of angiostatin and ionizing radiation in antitumour therapy

Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily

MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression

CBP501-calmodulin binding contributes to sensitizing tumor cells to cisplatin and bleomycin

CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity

A Phase I Trial of TNFerade Biologic in Patients with Soft Tissue Sarcoma in the Extremities

Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents

CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding

Manganese Superoxide Dismutase (SOD2) Inhibits Radiation-Induced Apoptosis by Stabilization of the Mitochondrial Membrane

CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice

CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathway

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches

MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer

Spatial and temporal control of gene therapy using ionizing radiation

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance

Suchergebnisse filtern